Navigation Links
Bhopal Gas Victims Get Spurious Drugs, Say Activists

Terming it as a 'citizens raid', Bhopal gas tragedy survivors' organisations claimed //to have seized a large number of sub-standard and expired drugs from two medical stores of the Bhopal Gas Tragedy Relief and Rehabilitation Department.

"A joint team of four organisations, working for the victims of the world's worst man-made industrial disaster, recovered many medicines that had crossed their expiry date," Rachna Dhingra of Bhopal Group of Information and Action (BGIA) said.

Addressing a press conference, she said of the 83 samples collected, more than 30 had passed their expiry date. The outdated medicines were antibiotics such as norfloxacin, ampicillin and tetracyclin.

Members of three other survivors' organisations - Bhopal Gas Peedit Mahila Stationery Karmachari Sangh (BGPMSKS), Bhopal Gas Peedit Mahila Purush Sangharsh Morcha (BGPMPSM) and Bhopal ki Awaaz (BKA) - were also present on the occasion.

"More than half of the samples collected were of medicines manufactured in Indore which is notorious for manufacturing spurious drugs," they said.

The activists alleged that despite the Supreme Court directives to send random samples of medicines for test at reputed laboratories, the state government has not taken any step in this regard.



Source-IANS
'"/>




Page: 1

Related medicine news :

1. Doctors Resign from Hospital for Bhopal Gas Victims
2. Bhopal Residents Relish Chicken despite Bird Flu Scare
3. State Govt To Provide Safe Drinking Water To Bhopal Gas Victims
4. Bhopal Archbishop’s Concern Over Maternal Mortality Rat
5. Six More Bhopal Gas Tragedy Continues to Take Toll
6. 500 People Affected by Gas Leak Near Bhopal
7. Children of Bhopal Gas Victims Suffer from Deformity
8. Funds Increased for Treating Bhopal Gas Victims
9. Bhopal Gas Victims Demand Treatment of Children With Birth Defects
10. Snail venom Found To Ease Pain In Cancer Victims
11. Patients Suffering From Severe Mental Diseases Are At Risk Of Being Crime Victims
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... 2017 , ... Connecticut Dermatology Group (CDG) is proud and excited to welcome ... Dr. Kim brings an extensive background in cutting-edge dermatology care and research to ... welcome back Dr. Kim to the CDG team” said President and Managing Partner Dr. ...
(Date:1/19/2017)... ... , ... Sales Focus Inc. (SFI), a Maryland-based sales outsourcing company, announced today ... past 20 years SFI has been recognized as the world’s leader in Intelligent Sales ... the US market. The new clients include: Panacea Pro, Campseekers, Contentmart, Stress Pal, ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Infinity® Massage Chairs ... plan and implement new sales and marketing strategies. Grover comes with a total of ... 5 and a half years as Executive Vice President of Direct Sales at Traeger® ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... of Proctology) announced today the opening of 3 medical offices specializing specifically ... Hemorrhoids Center of Los Angeles (Beverly Hills), Hemorrhoids Center of Newport Beach, ...
(Date:1/18/2017)... ... 18, 2017 , ... A recent video posting of a new fidget product ... of fidgeting to relieve stress and anxiety. No one was more surprised than ... had just completed a successful Kickstarter campaign raising $67,000 on the popular crowdfunding platform. ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... PHILADELPHIA , Jan. 18, 2017 The Philadelphia ... three companies developing medical devices for children. The Consortium ... to receive seed grants of $50,000 each. The ... amplifies weak nerve signals, a hand-operated rapid blood delivery system ... ears in babies. ...
(Date:1/18/2017)... , Jan. 18, 2017   Regenicin, Inc. ... biotechnology company specializing in the development and commercialization of ... tissues and organs, recently reported the Company,s operating results ... 2017. As the Company described in its ... a year of substantial accomplishments. The Company,s contract laboratory ...
(Date:1/18/2017)... 2017  Dermata Therapeutics, LLC, a biotechnology company ... variety of dermatological diseases, announces dosing the first ... Phase 2 acne rosacea study. DMT210 is a ... cytokines in the skin responsible for the inflammation ... This clinical trial, DMT210-003, is a 12-week, ...
Breaking Medicine Technology: